Beckman Coulter, Inc.

Beckman Coulter, Inc., through its US Customer Operations Division, supplies biomedical laboratory instrumentation, flow cytometry systems, centrifuges, liquid handling equipment, reagents, and comprehensive maintenance and technical support services to federal healthcare, research, and diagnostic missions as a prime contractor on full-and-open federal acquisitions with no set-aside posture. The company is a for-profit subsidiary of Danaher Corporation, headquartered in Brea, California, with corporate structure spanning multiple life-sciences manufacturers and diagnostic instrument divisions. As a manufacturer of goods operating under NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and primary PSC 6640 (Laboratory Equipment and Supplies) and PSC J066 (Maintenance, Repair, and Rebuilding of Equipment—Instruments and Laboratory Equipment), Beckman Coulter competes in the full-and-open federal marketplace without small business set-asides, reflecting its large-company status and specialized equipment position where competitive alternatives are typically limited.

Beckman Coulter's federal capability portfolio centers on specialized laboratory analytical equipment and field support. Representative prime work includes a $1.35 billion single-award indefinite delivery contract with Veterans Integrated Service Network 8 (Department of Veterans Affairs) for automated flow cytometry cost per reportable result services through March 2031; a $1.69 million single-award IDC with the Defense Health Agency for flow cytometry equipment and services across military medical facilities through September 2030; a $6 million single-award indefinite delivery contract with the Office of Logistics and Acquisition Operations for biomedical laboratory equipment, reagents, software, maintenance, and related services through May 2029; a $485,385 definitive contract with the U.S. Secret Service for preventative maintenance and repair on automated liquid handling equipment (Biomek i7 Hybrid and Biomek i5 Span-8 units) through June 2030; a $657,853 purchase order from the National Institute of Standards and Technology for an Analytical Ultracentrifuge Instrument Suite through February 2029; and a $418,786 delivery order from Veterans Integrated Service Network 17 for flow cytometry reagents and supplies. Recent representative delivery orders include $339,003 from the Defense Health Agency for flow cytometry equipment and services at Madigan Army Medical Center; $203,385 from the Indian Health Service for laboratory urinalysis testing equipment and supplies at the Tohatchi Health Center through September 2029; $207,303 from the EPA's Office of Chemical Safety and Pollution Prevention for maintenance of an ECHO 550 Acoustic Liquid Handler through March 2031; and $192,004 from Veterans Integrated Service Network 23 for Beckman flow cytometry maintenance at the VA Nebraska-Western Iowa Health Care System through August 2030.

Customer concentration reflects strong presence across federal healthcare and research institutions. The top five funding agencies by award count account for 15 percent of recent awards, led by the Department of the Army (265 awards), the Department of Health and Human Services Indian Health Service (248 awards), and the National Cancer Institute within NIH (229 awards). By combined potential value, the Veterans Affairs Veterans Integrated Service Network 4 anchors the portfolio ($17.8 million across 87 awards), followed by the Army Medical Command ($15.8 million across 184 awards) and VA VISN 16 ($12.7 million across 70 awards). This concentration signals sustained reliance by VA regional networks and military medical commands on Beckman Coulter's flow cytometry and centrifuge capabilities for diagnostic testing and clinical operations. Over 7,235 total awards with a combined potential value of $5.39 billion across 178 distinct customer agencies underscores deep market penetration across civilian health agencies, defense medical facilities, and research institutions.

Beckman Coulter places task orders and delivery orders under multiple parent vehicles. The Federal Supply Schedule GS24F7404A carries 751 task orders worth $538.9 million combined potential value. An indefinite delivery contract numbered 263020001 anchors the largest dollar vehicle with 699 task orders valued at $4.31 billion—substantially more than Beckman Coulter's own stated three principal IDCs totaling $19.69 million, indicating the source's broader portfolio coverage across all Danaher divisions and subsidiaries. Additional vehicles include IDC HHSN263200700016I (666 task orders, $5.6 million), Federal Supply Schedule V797P4736A (341 task orders, $64.3 million), and IDC 75N98018D00021 (283 task orders, $7.4 million). Beckman Coulter's specific named single-award vehicles include the $6 million Office of Logistics and Acquisition Operations IDC for biomedical laboratory equipment through May 2029; the $1.69 million Defense Health Agency IDC for flow cytometry equipment through September 2030; the $1.35 billion VA VISN 8 IDC for automated flow cytometry services through March 2031; a $345,000 USDA Veterinary Services IDC for centrifuge maintenance through March 2028; and a $10 million Office of Logistics and Acquisition Operations blanket purchase agreement for laboratory supplies through October 2026.

Activity has remained steady to slightly declining across five years—113 awards in 2022, declining to 31 awards in 2026 year-to-date—reflecting consistent but not growth-trajectory engagement. Over the next twenty-four months, 57 awards with combined potential value of $6.8 million reach ultimate completion date, creating moderate recompete exposure. In subcontract roles, Beckman Coulter supplies liquid handling equipment and laboratory automation systems to Astrix Technology LLC on a National Human Genome Research Institute high-throughput genotyping contract; provides Biomek robotic systems to Excet, LLC for DEVCOM CBC biodefense research and development; and delivers laboratory equipment to Triad National Security, LLC supporting Los Alamos National Laboratory operations management competition. Additional sub-awards under state pass-through entities (Montana Department of Health and Human Services) cover NHANES data collection support.

Beckman Coulter operates as 100 percent prime on the federal landscape; sub-awards represent less than 1 percent of total activity and appear peripheral to core business. The vendor's federal footprint reflects singular positioning: as a manufacturer of specialized diagnostic and analytical instrumentation with established sole-source and preferred-vendor relationships across health agencies, research institutes, and military medical commands, the company commands non-competitive procurement pathways and commands substantial recurring maintenance and reagent revenue streams from installed base. With 2,787 awards under Analytical Laboratory Instrument Manufacturing NAICS and 1,693 under Laboratory Equipment and Supplies PSC, Beckman Coulter demonstrates deep category domination in federal biomedical laboratory procurement.